Podopharm Jakub Oleszek sp. k. (Poland)

Main Activities: Toilet Preparation Manufacturing

Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Research and Development in the Social Sciences and Humanities

Full name: Podopharm Jakub Oleszek sp. k.

Profile Updated: June 18, 2025

Podopharm Jakub Oleszek sp. k. is based in Poland, with the head office in Kielce. The company operates in the Toilet Preparation Manufacturing sector. It was incorporated on October 10, 2019. From the latest financial highlights, Podopharm Jakub Oleszek sp. k. reported a net sales revenue increase of 21.84% in 2024. Its’ total assets recorded a growth of 35.41%. In, 2024, the company’s net profit margin decreased by 2.41%.

Headquarters
Ul. Ignacego Lukasiewicza 5
Kielce; Swietokrzyskie; Postal Code: 25-663

Contact Details: Purchase the Podopharm Jakub Oleszek sp. k. report to view the information.

Basic Information

Financial Auditors:

Purchase the Podopharm Jakub Oleszek sp. k. report to view the information.

Incorporation Date:

October 10, 2019

Key Executives

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Limited Partner

Purchase this report to view the information.

Limited Partner

Company Performance

Financial values in the chart are available after Podopharm Jakub Oleszek sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

21.84%▲

Total operating revenue

23.53%▲

Operating profit (EBIT)

3.62%▲

EBITDA

6.85%▲

Net Profit (Loss) for the Period

14.33%▲

Total Assets

35.41%▲

Total Equity

62.95%▲

Operating Profit Margin (ROS)

-6.7%▼

Net Profit Margin

-2.41%▼

Return on Equity (ROE)

-16.43%▼

Debt/Equity

-11.54%▼

Quick Ratio

-0.21%▼

Cash Ratio

-0.11%▼

Similar companies